Mediastinal gray zone lymphoma: The missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma

American Journal of Surgical Pathology

Volumn 29, Issue 11, 2005, Pages 1411-1421

  Traverse Glehen, Alexandra ^a,d   Pittaluga, Stefania ^a   Gaulard, Philippe ^b   Sorbara, Lynn ^a   Alonso, Miguel A ^c   Raffeld, Mark ^a   Jaffe, Elaine S ^e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e MSC 1500 ^*  (United States)

Author keywords

Classic Hodgkin's disease; Composite lymphoma; Gray zone lymphoma; Immunohistochemistry; Morphology; Nodular sclerosis Hodgkin's lymphoma; Primary mediastinal large B cell lymphoma; Transcription factor

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; COMPOSITE LYMPHOMA; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LASER CAPTURE MICRODISSECTION; MALE; MEDIASTINAL GRAY ZONE LYMPHOMA; MEDIASTINUM TUMOR; NODULAR SCLEROSIS HODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; VIRUS DETECTION;

ADOLESCENT; ADULT; FEMALE; HODGKIN DISEASE; HUMANS; LYMPHOMA, B-CELL; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED;

EID: 27244446911     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000180856.74572.73     Document Type: Article

References (58)

1. Barth TF, Leithauser F, Joos S, et al. Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol. 2002;3:229-234.
2. Bentz M, Barth TF, Bruderlein S, et al. Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer. 2001;30:393-401.
3. Boudova L, Torlakovic E, Delabie J, et al. Nodular lymphocyte predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte rich B-cell lymphoma: differential diagnosis between nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte rich B-cell lymphoma. Blood. 2003;24:24.
4. Cazals-Hatem D, Andre M, Mounier N, et al. Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study. Am J Surg Pathol. 2001;25:297-306.
5. Cong P, Raffeld M, Teruya-Feldstein J, et al. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood. 2002;99:3376-3382.
6. Copie-Bergman C, Gaulard P, Maouche-Chretien L, et al. The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood. 1999; 94:3567-3575.
7. Copie-Bergman C, Plonquet A, Alonso MA, et al. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol. 2002;15: 1172-1180.
8. Falini B, Venturi S, Martelli M, et al. Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol. 1995;89:780-789.
9. Fend F, Quintanilla-Martinez L, Kumar S, et al. Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas: a molecular analysis using laser capture microdissection. Am J Pathol. 1999;154:1857-1866.
10. Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood. 1999;94: 3108-3113.
11. Garcia JF, Mollejo M, Fraga M, et al. Large B-cell lymphoma with Hodgkin's features. Histopathology. 2005;47:101-110.
12. Gonzalez CL, Medeiros LJ, Jaffe ES. Composite lymphoma: a clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma. Am J Clin Pathol. 1991;96:81-89.
13. Hertel CB, Zhou XG, Hamilton-Dutoit SJ, et al. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene. 2002; 21:4908-4920.
14. Hummel M, Ziemann K, Lammert H, et al. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med. 1995;333:901-906.
15. Jaffe ES. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol. 2001;14:219-228.
16. Jaffe ES, Wilson WH. Gray zone, synchronous, and metachronous lymphomas: diseases at the interface of non-Hodgkin's lymphomas and Hodgkin's Lymphoma. In: Mauch PM, Armitage JO, Coiffier B, et al, eds. Non-Hodgkin's Lymphoma. Philadelphia: Lippincott Williams and Wilkins, 2004:69-80.
17. Jaffe ES, Zarate-Osorno A, Kingma DW, et al. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. Ann Oncol. 1994;5(suppl 1):7-11.
18. Joos S, Kupper M, Ohl S, et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res. 2000;60:549-552.
19. Joos S, Otano-Joos MI, Ziegler S, et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood. 1996;87:1571-1578.
20. Jox A, Wolf J, Diehl V. Hodgkin's disease biology: recent advances. Hematol Oncol. 1997;15:165-171.
21. Jundt F, Kley K, Anagnostopoulos I, et al. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood. 2002;99:3060-3062.
22. Kanavaros P, Gaulard P, Charlotte F, et al. Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B-cell lymphomas. Am J Pathol. 1995;146: 735-741.
23. Krenacs L, Himmelmann AW, Quintanilla-Martinez L, et al. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Blood. 1998;92:1308-1316.
24. Krikorian JG, Burke JS, Rosenberg SA, et al. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N Engl J Med. 1979;300:452-458.
25. Kuppers R, Kanzler H, Hansmann ML, et al. Single cell analysis of Hodgkin/Reed-Sternberg cells. Ann Oncol. 1996;7(suppl 4):27-30.
26. Leithauser F, Bauerle M, Huynh MQ, et al. Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma. Blood. 2001;98:2762-2770.
27. Marafioti T, Hummel M, Anagnostopoulos I, et al. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol. 1999;17:3804-3809.
28. Marafioti T, Hummel M, Foss HD, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 2000;95:1443-1450.
29. Mounier N, Briere J, Gisselbrecht C, et al. Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). Blood. 2003;101: 4279-4284.
30. Ohno T, Smir BN, Weisenburger DD, et al. Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with 'Hodgkin's transformation.' Blood. 1998;91:1757-1761.
31. Ohno T, Trenn G, Wu G, et al. The clonal relationship between nodular sclerosis Hodgkin's disease with a clonal Reed-Sternberg cell population and a subsequent B-cell small noncleaved cell lymphoma. Mod Pathol. 1998;11:485-490.
32. Ohshima K, Suzumiya J, Mukai Y, et al. Classical Hodgkin and Reed-Sternberg cells demonstrate a non-clonal immature B lymphoid lineage: evidence from a single cell assay and in situ hybridization. Hematol Oncol. 1996;14:123-136.
33. Otsuki T, Kumar S, Ensoli B, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia. 1996;10:1358-1362.
34. Parrens M, Vergier B, Fitoussi O, et al. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells. Am J Surg Pathol. 2002;26:1634-1642.
35. Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis: a clinicopathologic study of 60 cases. Am J Surg Pathol. 1986;10:176-191.
36. Pileri S, Bocchia M, Baroni C, et al. Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinicopathologic study of 69 cases. Br J Haematol. 1994;86:513-523.
37. Pileri SA, Gaidano G, Zinzani PL, et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol. 2003;162:243-253.
38. Portlock CS, Donnelly GB, Qin J, et al. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. Br J Haematol. 2004;125:701-708.
39. Qin XF, Reichlin A, Luo Y, et al. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J. 1998;17:5066-5075.
40. Ramasamy I, Brisco M, Morley A. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. J Clin Pathol. 1992;45:770-775.
41. Re D, Muschen M, Ahmadi T, et al. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. Cancer Res. 2001;61:2080-2084.
42. Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851-862.
43. Roth J, Daus H, Trumper L, et al. Detection of immunoglobulin heavy-chain gene rearrangement at the single-cell level in malignant lymphomas: no rearrangement is found in Hodgkin and Reed-Sternberg cells. Int J Cancer. 1994;57:799-804.
44. Rubin D, Hudnall SD, Aisenberg A, et al. Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr viras infection. Mod Pathol. 1994;7:91-98.
45. Rudiger T, Jaffe ES, Delsol G, et al. Workshop report on Hodgkin's disease and related diseases ('gray zone' lymphoma). Ann Oncol. 1998; 9(suppl 5):31-38.
46. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871-3879.
47. Schebesta M, Heavey B, Busslinger M. Transcriptional control of B-cell development. Curr Opin Immunol. 2002;14:216-223.
48. Schmid C, Pan L, Diss T, et al. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol. 1991;139:701-707.
49. Schubart DB, Rolink A, Kosco-Vilbois MH, et al. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature. 1996;383:538-542.
50. Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97:496-501.
51. Taddesse-Heath L, Pittaluga S, Sorbara L, et al. Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol. 2003;27:522-531.
52. Torlakovic E, Tierens A, Dang HD, et al. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte pre-dominance, but not classical Hodgkin's disease. Am J Pathol. 2001;159: 1807-1814.
53. Torlakovic E, Torlakovic G, Nguyen PL, et al. The value of anti-Pax-5 immunostaining in routinely fixed and paraffin-embedded sections-A novel pan pre-B and B-cell marker. Am J Surg Pathol. 2002;26:1343-1350.
54. Traverse-Glehen A, Pittaluga S, Wilson WH, et al. Mediastinal gray zone lymphoma: the missing link between classical Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Eur J Haematol. 2004;73: 15.
55. von Wasielewski R, Mengel M, Fischer R, et al. Classical Hodgkin's disease: clinical impact of the immunophenotype. Am J Pathol. 1997;151: 1123-1130.
56. Wilson WH, Gutierrez M, O'Connor P, et al. The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R. Semin Oncol. 2002;29:41-47.
57. Zarate-Osorno A, Medeiros LJ, Longo DL, et al. Non-Hodgkin's lymphomas arising in patients successfully treated for Hodgkin's disease: a clinical, histologic, and immunophenotypic study of 14 cases. Am J Surg Pathol. 1992;16:885-895.
58. Zinzani PL, Martelli M, Magagnoli M, et al. Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood. 1998;92:790-794.